文献速递创伤骨科

掌侧钢板固定桡骨远端骨折后手术部位多模式药物注射是否改善疼痛评分?

Does Surgical-site Multimodal Drug Injection After Palmar Plating of Distal Radius Fractures Improve Pain Scores?
PubMed 文献 · Clin Orthop Relat Res · 2020-01-01

一项随机对照研究纳入101例全身麻醉下掌侧钢板固定的桡骨远端骨折患者,比较手术部位多模式药物注射与不注射的疗效。结果显示注射组在4、8、24小时VAS评分虽统计学更低,但均未达到20分的最小临床重要差异;48小时无差异。注射组48小时内芬太尼用量更低,接受止吐药的患者比例更少。

要点

  • 多模式注射未在4、8、24、48小时VAS评分上达到20分MCID的临床重要改善。
  • 注射组48小时内芬太尼消耗量中位数25 μg,低于对照组的37.5 μg。
  • 注射组接受止吐药比例16%,低于对照组的35%。

核心结论

  • 掌侧钢板固定桡骨远端骨折后手术部位多模式镇痛注射未带来临床重要的疼痛评分降低,但减少了术后48小时内阿片类药物用量和止吐药使用。

主要发现

  • VAS评分在4小时为34±15 vs 41±20(均差-7.079,95%CI -13.986至-0.173,p=0.045),8小时为27±16 vs 40±19(均差-12.263,95%CI -19.174至-5.353,p=0.001),24小时为18±12 vs 29±20(均差-11.042,95%CI -17.664至-4.419,p=0.001),48小时为9±8 vs 10±6(均差-1.318,95%CI -4.000至1.365,p=0.33)。
  • 术后48小时内芬太尼消耗量注射组为25 μg(范围0-100 μg),对照组为37.5 μg(范围0-125 μg),中位数差-12.5,p=0.01。
  • 接受止吐药的患者比例注射组为16%(8/50),对照组为35%(17/48),比值比=2.879(95%CI 1.102至7.519),p=0.03。

关键数值与推荐

  • VAS评分最小临床重要差异(MCID)设定为20 mm。
  • 多模式注射组在掌侧钢板固定后于骨膜区、旋前方肌、皮下区和皮肤注射罗哌卡因10 mL、吗啡5 mL、头孢唑林5 mL及生理盐水5 mL。
  • 术后疼痛时静脉注射芬太尼25 μg,出现恶心呕吐时注射止吐药。

临床怎么用

  • 对于掌侧钢板固定的桡骨远端骨折患者,可考虑手术部位多模式药物注射以减少术后阿片类药物用量和止吐药需求,但不应期望达到临床重要的疼痛评分改善。

局限性

  • 单中心研究,样本量有限,最终分析每组不足50例。
  • 疼痛评分未在全部时间点完整注册导致部分患者被排除。
  • 未报告其他镇痛方式或长期功能结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Although palmar locked plating is a stable fixation method frequently used to treat unstable distal radius fractures (DRFs), surgical treatment may be painful, and so interventions to decrease that pain might improve our patients' experiences with surgery. Some surgeons use local multimodal drug injections to decrease postoperative pain after lower-extremity arthroplasty, but little is known about the effectiveness of a local multimodal drug injection in patients who undergo palmar plating for DRFs. QUESTIONS/PURPOSES: (1) Do patients who receive a local multimodal drug injection after palmar plating for unstable DRFs have better pain scores at 4, 8, 24, and 48 hours after surgery than patients who have not received such an injection? (2) Do patients who receive a local multimodal drug injection have lower fentanyl consumption and administration of anti-emetic drugs within the first 48 hours after surgery than patients who have not received such an injection? METHODS: A randomized controlled study was performed between August 2018 and August 2019 at a single tertiary care referral center. Patients who underwent palmar plating for DRFs under general anesthesia were eligible for inclusion. Patients were allocated into two groups: Those who received a local multimodal drug injection, and those who did not receive an injection. During the study period, 101 patients treated with palmar plating for DRFs met the inclusion criteria and were enrolled and randomized. Fifty-two patients were allocated to the multimodal injection group and 49 were allocated to the control group. Three patients (two in the multimodal injection group and one in the control group) were excluded after randomization because their pain level was not registered at any timepoint and so they could not be analyzed; our analysis was by intention to treat, and there was no crossover. After palmar plating, patients in the multimodal injection group received an injection of ropivacaine (10 mL), morphine (5 mL), ceftezole (5 mL) as well as normal saline (5 mL) to the periosteal area, pronator quadratus muscle, subcutaneous area, and skin. There were no differences between the groups in terms of age (62 years ± 13 years in the multimodal injection group versus 62 years ± 11 years in the control group; p = 0.93), gender (84% [42 of 50] women in the multimodal injection group versus 77% [37 of 48] women in the control group; p = 0.39), hand dominance (70% [35 of 50] dominant wrist in the multimodal injection group versus 60% [29 of 48] dominant wrist in the control group; p = 0.32) and AO/Orthopaedic Trauma Association (AO/OTA) classification (p = 0.57). All patients underwent treatment with the same perioperative protocol, and 25 μg of fentanyl was injected intravenously when a patient complained of pain and asked for additional pain control after surgery. In addition, when a patient complained of nausea or vomiting associated with fentanyl use, an anti-emetic drug was also injected. All nursing staff who administered the analgesics and anti-emetic drugs were blinded to treatment allocation. These two groups were compared regarding their pain level using a 100-mm VAS at 4, 8, 24, and 48 hours postoperatively. The minimum clinically important difference (MCID) for the VAS score was set to 20 mm. VAS scores were also collected by nursing staff who remained blinded to the treatment allocation. The total amount of fentanyl use and the number of patients who received anti-emetic drugs associated with administration of fentanyl within the first 48 hours were also recorded. RESULTS: With an MCID of 20 points, we found no clinically important reduction in VAS scores among patients who received a local multimodal injection compared with those who did not receive an injection at 4 hours (34 ± 15 versus 41 ± 20, mean difference -7.079 [95% CI -13.986 to -0.173]; p = 0.045), 8 hours (27 ± 16 versus 40 ± 19, mean difference -12.263 [95% CI -19.174 to -5.353]; p = 0.001), 24 hours (18 ± 12 versus 29 ± 20, mean difference -11.042 [95% CI -17.664 to -4.419]; p = 0.001), and 48 hours (9 ± 8 versus 10 ± 6, mean difference -1.318 [95% CI -4.000 to 1.365]; p = 0.33). Within the first 48 hours after surgery, fentanyl consumption was lower in patients receiving a local multimodal injection than in control patients (25 μg [range 0-100 μg] versus 37.5 μg [range 0-125 μg], difference of medians -12.5; p = 0.01). There was also a difference between the study groups in terms of the proportion of patients who received anti-emetic medications (16% [8 of 50] in the multimodal injection group versus 35% [17 of 48] in the control group, odds ratio = 2.879 [95% CI 1.102 to 7.519]; p = 0.03). CONCLUSIONS: Our data suggest that patients who received a surgical-site multimodal analgesic injection after palmar plating for a distal radius fracture had no clinically important reduction in pain scores, but they did consume lower doses of opioid analgesics and fewer of these patients received anti-emetic drugs within 2 days of surgery. The high-potency opioids or other analgesia usually used for postoperative pain management have many side effects. Thus, reducing additional analgesia is as important as postoperative pain management and a surgical-site multimodal analgesic injection is one of the methods to achieve this a goal. LEVEL OF EVIDENCE: Level I, therapeutic study.

来源:Clin Orthop Relat Res,查看原文。版权归原作者所有。

引用

  1. Jung HS, Chun KJ, Kim JY, et al. Does Surgical-site Multimodal Drug Injection After Palmar Plating of Distal Radius Fractures Improve Pain Scores? Clin Orthop Relat Res. 2020. PMID: 32187097. doi:10.1097/CORR.0000000000001212

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。